Alerts will be sent to your verified email
Verify EmailSUNPHARMA
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Sun Pharmaceutical Industries Limited is a leading specialty generic pharmaceutical company in India, offering a wide range of high-quality and affordable products globally.
Sun Pharma Inds. major competitors are Cipla, Torrent Pharma, Mankind Pharma, Dr. Reddy's Lab, Lupin, Zydus Lifesciences, Aurobindo Pharma.
Market Cap of Sun Pharma Inds. is ₹4,16,393 Crs.
While the median market cap of its peers are ₹95,466 Crs.
Sun Pharma Inds. seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
Earnings Release | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Jun Dec | |||
Investor Presentation | Mar Jun Sep Nov Dec | Jan Mar Jun Sep Dec | Jan Mar Jun Sep Dec | Mar Jun Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Jun Sep Dec | Mar Jun Sep | Sep Dec | ||||||||
Conference Call | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Sep Dec | |||
Conference Call SummaryCon Call Summary
Powered by Gemini
|